Adage Capital Partners Gp, L.L.C. Mirum Pharmaceuticals, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 80,000 shares of MIRM stock, worth $4.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
80,000
Previous 160,000
50.0%
Holding current value
$4.04 Million
Previous $5.47 Million
42.96%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
197Shares Held
54.3MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$332 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$226 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$174 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$163 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$155 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.85B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...